Clinical trial
Evaluation of the Safety and Efficacy of an Advanced Therapy Medicinal Product Containing Live ASCs in the Treatment of Diabetic Foot Syndrome - a Double-blind, Randomized Study.
NCT06843122 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Safety and Efficacy of an Advanced Therapy Medicinal Product Containing Live ASCs in the Treatment of Diabetic Foot Syndrome - a Double-blind, Randomized Study.
- Lead sponsor
- Medical University of Warsaw
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- March 8, 2025
- Completion date
- August 1, 2027
- Enrollment
- 105 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot ulcer